PLEXCOVID-19 Trademark

Trademark Overview

On Monday, May 4, 2020, a trademark application was filed for PLEXCOVID-19 with the United States Patent and Trademark Office. The USPTO has given the PLEXCOVID-19 trademark a serial number of 88899160. The federal status of this trademark filing is REGISTERED as of Tuesday, June 14, 2022. This trademark is owned by PLEXISION, INC. The PLEXCOVID-19 trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical blood testing for diagnostic purposes to measure cell-mediated immunity to the SARS-CoV-2 virus
plexcovid-19

General Information

Serial Number88899160
Word MarkPLEXCOVID-19
Filing DateMonday, May 4, 2020
Status700 - REGISTERED
Status DateTuesday, June 14, 2022
Registration Number6761091
Registration DateTuesday, June 14, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 7, 2021

Trademark Statements

Goods and ServicesMedical blood testing for diagnostic purposes to measure cell-mediated immunity to the SARS-CoV-2 virus

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateNOT AVAILABLE
Primary Code044
First Use Anywhere DateWednesday, October 7, 2020
First Use In Commerce DateWednesday, October 7, 2020

Trademark Owner History

Party NamePLEXISION, INC
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPITTSBURGH, PA 15224
Party NamePLEXISION, INC
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPITTSBURGH, PA 15224
Party NamePLEXISION, INC
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPITTSBURGH, PA 15224

Trademark Events

Event DateEvent Description
Tuesday, June 14, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 14, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, May 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, May 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, May 4, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, April 20, 2022USE AMENDMENT FILED
Wednesday, May 4, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 20, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, November 2, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 7, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 7, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 18, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 21, 2021ASSIGNED TO LIE
Saturday, July 3, 2021NOTICE OF REVIVAL - E-MAILED
Friday, July 2, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 2, 2021PETITION TO REVIVE-GRANTED
Friday, July 2, 2021TEAS PETITION TO REVIVE RECEIVED
Thursday, May 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 20, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, May 20, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, November 4, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 4, 2020NON-FINAL ACTION E-MAILED
Wednesday, November 4, 2020NON-FINAL ACTION WRITTEN
Monday, November 2, 2020ASSIGNED TO EXAMINER
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 7, 2020NEW APPLICATION ENTERED IN TRAM

Related Keywords

plexcovid mediated immunity sars virus cell measure blood testing diagnostic purposes